............................ 20 1.2 Rationale for Vesigenurtacel -L Development ................................ ................................ ............. 21 1.3 Description of Investigational Agent Vesigenurtacel -L ................................ .............................. 22 1.4 Prior Human Experience ................................ ................................ ................................ ............. 23 2.0 OBJECTIVES ................................ ................................ ................................ ................................ .23 2.1 Primary Objective ................................ ................................